Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

6.18
Delayed Data
As of Aug 31
 -0.24 / -3.74%
Today’s Change
5.25
Today|||52-Week Range
18.42
-56.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues256.0K569.0K1.2M2.5M
 
 
 
 
 
Cost of Goods Sold57.0K220.0K390.0K612.0K
 
 
 
 
 
Depreciation And Amortization97.0K121.0K138.0K145.0K
 
 
 
 
 
 
Operating ExpensesGross Income102.0K228.0K647.0K1.8M
 
 
 
 
 
General Expenses35.5M39.9M28.5M28.7M
 
 
 
 
 
Research And Development19.1M5.8M9.6M8.0M
 
 
 
 
 
Total Operating Expenses35.7M40.2M29.0M29.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-35.4M-39.6M-27.8M-27.0M
 
 
 
 
 
Other Expenses0.0052.0K107.0K114.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-35.3M-39.6M-27.7M-26.9M
 
 
 
 
 
Income Taxes0.00-700.0K-22.0K-23.0K
 
 
 
 
Net Income-35.3M-40.3M-27.7M-26.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS91.8M92.1M100.6M104.6M
 
 
 
 
 
Shares To Calculate EPS Diluted91.8M92.1M100.6M104.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.38-$0.44-$0.28-$0.26
 
 
 
 
 
EPS Diluted-$0.38-$0.44-$0.28-$0.26